A consulting firm was working on behalf of a client to develop investment theses in the gene therapy manufacturing space.

The client wanted to learn from biopharma experts with 15-20+ years of experience who could speak about viral vectors, DNA editing, transfection cells, and any important regulatory or R&D changes.

The project required expertise from a range of specialties. GLG sourced a selection of Network Members with experience in viral vector manufacturing, cell therapy development, large pharma, and clinical development.

The client conducted six in-depth interviews with GLG’s expert panel, including a business development director for cell therapy, a vector R&D director, a gene therapy process developer, and a researcher in target drug discovery.

The client gained an understanding of the gene therapy manufacturing industry, namely the key players, future trends, and regulatory considerations.

The team used these insights to advise on investment opportunities for the next three to five years.